The role of TIGAR in balancing redox state in cancer cells has also been implicated in multiple myeloma cells, where inhibition of the oncoprotein MUC1-C resulted in a downregulation of TIGAR protein, lower levels of NADPH and in turn, increased ROS and cell death[69]. Here, TIGAR is linked to plasma cell myeloma.